Infectious Diseases
News from the FDA/CDC
FDA expands Xofluza indication to include postexposure flu prophylaxis
From the Journals
Rationale for baricitinib’s use in COVID-19 patients demonstrated
“We went from modeling and mechanistic investigations to clinical tests in a number of settings and laboratory analysis in record time,” Dr....
From the Journals
Antidepressant shows early promise for mild COVID-19
The findings on fluvoxamine “need to be interpreted as hypothesis generating rather than as a demonstration of efficacy,” the study authors wrote...
Conference Coverage
Harnessing the HIV care continuum model to improve HCV treatment success
Substance use, trauma histories, and mental health problems can negatively affect HCV care engagement.
Conference Coverage
Abnormal anal paps in people with HIV can go more than a year without follow-up
In the U.S., people living with HIV are 19 times more likely to develop anal cancer, according to a journal article.
Conference Coverage
‘Uptake is only the first step’ for effective HIV PrEP protection
Follow-up in patients who received HIV PrEP prescriptions through a Detroit program was under 50%.
From the Journals
‘Hospital at home’ increases COVID capacity in large study
Atrium Health developed a “hospital at home” program for COVID patients and brought it online in just 2 weeks.
Conference Coverage
Metapneumovirus infections clinically indistinguishable from flu, RSV
Feature
'Tragic' milestone: 1 million children with COVID-19
“We haven’t seen a virus flash through our communities in this way since before we had vaccines for measles and polio.”
From the Journals
Opt-out policy at a syringe service program increased HIV/HCV testing
For HIV and HCV among people who inject drugs, it is important to improve diagnosis and linkage to care.
Commentary
Should our patients really go home for the holidays?
Risks to warn patients of include high-risk status, risk of SARS-CoV-2 transmission and how to mitigate it, and mode of transportation.